The Role of Cytokines in the Different Stages of Hepatocellular Carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Cytokines in the Different Stages of Hepatocellular Carcinoma
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 19, Pages 4876
Publisher
MDPI AG
Online
2021-09-29
DOI
10.3390/cancers13194876
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cooperative Role of Thrombopoietin and Vascular Endothelial Growth Factor-A in the Progression of Liver Cirrhosis to Hepatocellular Carcinoma
- (2021) Barbara Vizio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epidemiology and surveillance for hepatocellular carcinoma: New trends
- (2020) Amit G. Singal et al. JOURNAL OF HEPATOLOGY
- OPN is a promising serological biomarker for hepatocellular carcinoma diagnosis
- (2020) Mingyu Zhu et al. JOURNAL OF MEDICAL VIROLOGY
- Biomarkers for the Early Detection of Hepatocellular Carcinoma
- (2020) Neehar D Parikh et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint
- (2020) Jörg Wischhusen et al. Frontiers in Immunology
- The CCL20-CCR6 Axis in Cancer Progression
- (2020) Suguru Kadomoto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma
- (2020) Wenjie Zhang et al. Journal for ImmunoTherapy of Cancer
- Peripheral cytokine levels as predictive biomarkers of benefit from immune checkpoint inhibitors in cancer therapy
- (2020) Shoujian Ji et al. BIOMEDICINE & PHARMACOTHERAPY
- IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells
- (2020) Yu Li et al. OncoTargets and Therapy
- Immune checkpoint inhibitors
- (2019) Enfu Hui JOURNAL OF CELL BIOLOGY
- Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade
- (2019) Ying Zhu et al. GUT
- Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma
- (2019) Michael Teufel et al. GASTROENTEROLOGY
- IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation
- (2019) Wenjun Ouyang et al. IMMUNITY
- Phase 2 study of pembrolizumab and circulating biomarkers to predict anticancer response in advanced, unresectable hepatocellular carcinoma
- (2019) Lynn G. Feun et al. CANCER
- DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway
- (2019) Wubin Guo et al. ONCOLOGY REPORTS
- IL-1 Family Members in Cancer; Two Sides to Every Story
- (2019) Kevin J. Baker et al. Frontiers in Immunology
- From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma
- (2019) Yaojie Fu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- TGF-β induced chemoresistance in liver cancer is modulated by xenobiotic nuclear receptor PXR
- (2019) Ella Bhagyaraj et al. CELL CYCLE
- DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation
- (2019) Ssu-Chuan Lai et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-Acting Antivirals
- (2018) Jose D. Debes et al. GASTROENTEROLOGY
- Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis
- (2018) Kristina Tzartzeva et al. GASTROENTEROLOGY
- Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
- (2018) Jorge A. Marrero et al. HEPATOLOGY
- Defining and Understanding Adaptive Resistance in Cancer Immunotherapy
- (2018) Tae Kon Kim et al. TRENDS IN IMMUNOLOGY
- IL-37 isoform D downregulates pro-inflammatory cytokines expression in a Smad3-dependent manner
- (2018) Mingsheng Zhao et al. Cell Death & Disease
- The role of osteopontin in the progression of solid organ tumour
- (2018) Hailin Zhao et al. Cell Death & Disease
- Use of checkpoint inhibitors in liver transplant recipients
- (2018) Stefan Munker et al. United European Gastroenterology Journal
- Monitoring Immune Checkpoint Regulators as Predictive Biomarkers in Hepatocellular Carcinoma
- (2018) Ritu Shrestha et al. Frontiers in Oncology
- IL-37b suppresses epithelial mesenchymal transition in hepatocellular carcinoma by inhibiting IL-6/STAT3 signaling
- (2018) Xing-Yu Pu et al. Hepatobiliary & Pancreatic Diseases International
- Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?
- (2018) Giorgia Marisi et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Monitoring serum proangiogenic cytokines from hepatocellular carcinoma patients treated with sorafenib
- (2018) Takuya Adachi et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Interleukin 6-dependent genomic instability heralds accelerated carcinogenesis following liver regeneration on a background of chronic hepatitis
- (2017) Tali Lanton et al. HEPATOLOGY
- High plasma interleukin-6 levels associated with poor prognosis of patients with advanced hepatocellular carcinoma
- (2017) Yu-Yun Shao et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Targeting hepatic macrophages to treat liver diseases
- (2017) Frank Tacke JOURNAL OF HEPATOLOGY
- IL-37 induces autophagy in hepatocellular carcinoma cells by inhibiting the PI3K/AKT/mTOR pathway
- (2017) Ting-Ting Li et al. MOLECULAR IMMUNOLOGY
- The role of IL-6 in host defence against infections: immunobiology and clinical implications
- (2017) Stefan Rose-John et al. Nature Reviews Rheumatology
- Intracellular IL-37b interacts with Smad3 to suppress multiple signaling pathways and the metastatic phenotype of tumor cells
- (2017) C Luo et al. ONCOGENE
- The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level
- (2017) et al. JAMA Oncology
- Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population
- (2016) T. Duarte-Salles et al. Cancer Prevention Research
- Regulation of Transdifferentiation and Retrodifferentiation by Inflammatory Cytokines in Hepatocellular Carcinoma
- (2016) Florian Cabillic et al. GASTROENTEROLOGY
- Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2016) Haidong Wang et al. LANCET
- Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma
- (2016) Roslyn Vongsuvanh et al. PLoS One
- Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development
- (2016) Juan Wang et al. Targeted Oncology
- Role of interleukin-6 in cancer progression and therapeutic resistance
- (2016) Neeraj Kumari et al. TUMOR BIOLOGY
- IL-37 suppresses hepatocellular carcinoma growth by converting pSmad3 signaling from JNK/pSmad3L/c-Myc oncogenic signaling to pSmad3C/P21 tumor-suppressive signaling
- (2016) Rui Liu et al. Oncotarget
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- Diagnostic and Prognostic Roles of Serum Osteopontin and Osteopontin Promoter Polymorphisms in Hepatitis B-related Hepatocellular Carcinoma
- (2015) Nitinan Chimparlee et al. Asian Pacific Journal of Cancer Prevention
- IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort study
- (2015) Jung-Ta Kao et al. BMC GASTROENTEROLOGY
- Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma
- (2015) M Sadeghi et al. BRITISH JOURNAL OF CANCER
- High Serum Transforming Growth Factor- 1 Levels Predict Outcome in Hepatocellular Carcinoma Patients Treated with Sorafenib
- (2015) T.-H. Lin et al. CLINICAL CANCER RESEARCH
- Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma
- (2015) Xiaoguang Li et al. GUT
- The yin and yang of evasion and immune activation in HCC
- (2015) Oxana V. Makarova-Rusher et al. JOURNAL OF HEPATOLOGY
- Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma
- (2015) Tianxiang Ge et al. MEDICAL ONCOLOGY
- Lack of gp130 expression in hepatocytes attenuates tumor progression in the DEN model
- (2015) M Hatting et al. Cell Death & Disease
- Su2042 Serum VEGF as a Tumor Marker for Patients With HCV-Related Liver Cirrhosis and Hepatocellular Carcinoma
- (2015) Takanori Mukozu et al. GASTROENTEROLOGY
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2015) et al. JOURNAL OF HEPATOLOGY
- Association of Serum Level of Growth Differentiation Factor 15 with Liver Cirrhosis and Hepatocellular Carcinoma
- (2015) Xiuying Liu et al. PLoS One
- Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
- (2014) Mark D. Turner et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
- (2014) J. M. Taube et al. CLINICAL CANCER RESEARCH
- Endothelial progenitors promote hepatocarcinoma intrahepatic metastasis through monocyte chemotactic protein-1 induction of microRNA-21
- (2014) Yu-Tsung Shih et al. GUT
- Osteopontin and latent-TGF β binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma
- (2014) Andre Nogueira da Costa et al. INTERNATIONAL JOURNAL OF CANCER
- TGF-β/Smad signaling during hepatic fibro-carcinogenesis (Review)
- (2014) KATSUNORI YOSHIDA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Pro-angiogenic cytokines for prediction of outcomes in patients with advanced hepatocellular carcinoma
- (2013) K Miyahara et al. BRITISH JOURNAL OF CANCER
- Changes in plasma vascular endothelial growth factor at 8 weeks after sorafenib administration as predictors of survival for advanced hepatocellular carcinoma
- (2013) Kaoru Tsuchiya et al. CANCER
- Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 Signaling
- (2013) Guobin He et al. CELL
- Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma
- (2013) Tamar Kapanadze et al. JOURNAL OF HEPATOLOGY
- Met as a therapeutic target in HCC: Facts and hopes
- (2013) Silvia Giordano et al. JOURNAL OF HEPATOLOGY
- Secretory/releasing proteome-based identification of plasma biomarkers in HBV-associated hepatocellular carcinoma
- (2013) Lei Yang et al. Science China-Life Sciences
- Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
- (2012) J. M. Llovet et al. CLINICAL CANCER RESEARCH
- Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development
- (2012) Kun Wu et al. HEPATOLOGY
- Rather than interleukin-27, interleukin-6 expresses positive correlation with liver severity in naïve hepatitis B infection patients
- (2012) Jung-Ta Kao et al. LIVER INTERNATIONAL
- A Novel Monoclonal Antibody to Fibroblast Growth Factor 2 Effectively Inhibits Growth of Hepatocellular Carcinoma Xenografts
- (2012) L. Wang et al. MOLECULAR CANCER THERAPEUTICS
- A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma
- (2011) Stephen L. Chan et al. CANCER
- Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury
- (2011) Christer Baeck et al. GUT
- Identification of osteopontin as a novel marker for early hepatocellular carcinoma
- (2011) Sufen Shang et al. HEPATOLOGY
- Oxidative stress is closely associated with tumor angiogenesis of hepatocellular carcinoma
- (2011) Masayasu Jo et al. JOURNAL OF GASTROENTEROLOGY
- Serum levels of β-catenin as a potential marker for genotype 4/hepatitis C-associated hepatocellular carcinoma
- (2011) Sayed Daoud ONCOLOGY REPORTS
- Selective Recruitment of Regulatory T Cell through CCR6-CCL20 in Hepatocellular Carcinoma Fosters Tumor Progression and Predicts Poor Prognosis
- (2011) Kang-Jie Chen et al. PLoS One
- A Role for the Chemokine RANTES in Regulating CD8 T Cell Responses during Chronic Viral Infection
- (2011) Alison Crawford et al. PLoS Pathogens
- Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents
- (2010) Le-Xing Yu et al. HEPATOLOGY
- Vascular endothelial growth factor in the management of hepatocellular carcinoma
- (2009) Ahmed O. Kaseb et al. CANCER
- Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-β signaling from tumor suppression to oncogenesis in early chronic hepatitis B
- (2009) Miki Murata et al. HEPATOLOGY
- Inhibition of c-Jun NH2-terminal kinase switches Smad3 signaling from oncogenesis to tumor- suppression in rat hepatocellular carcinoma
- (2009) Hiromitsu Nagata et al. HEPATOLOGY
- Hepatic recruitment of the inflammatory Gr1+monocyte subset upon liver injury promotes hepatic fibrosis
- (2009) Karlin Raja Karlmark et al. HEPATOLOGY
- Angiogenesis in liver disease
- (2009) Mercedes Fernández et al. JOURNAL OF HEPATOLOGY
- Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
- (2009) Hellmut G. Augustin et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- TGFβ in Cancer
- (2008) Joan Massagué CELL
- TRAF6 Mediates Smad-Independent Activation of JNK and p38 by TGF-β
- (2008) Motozo Yamashita et al. MOLECULAR CELL
- Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection
- (2008) Juan R Larrubia et al. WORLD JOURNAL OF GASTROENTEROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started